BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22457349)

  • 1. L-MPZ, a novel isoform of myelin P0, is produced by stop codon readthrough.
    Yamaguchi Y; Hayashi A; Campagnoni CW; Kimura A; Inuzuka T; Baba H
    J Biol Chem; 2012 May; 287(21):17765-17776. PubMed ID: 22457349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phylogenetically Conserved Sequences Around Myelin P0 Stop Codon are Essential for Translational Readthrough to Produce L-MPZ.
    Yamaguchi Y; Baba H
    Neurochem Res; 2018 Jan; 43(1):227-237. PubMed ID: 29081003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of novel readthrough agents on myelin protein zero translation in the peripheral nervous system.
    Otani Y; Taguchi A; Hamada K; Hayashi Y; Yamaguchi Y; Baba H
    Neuropharmacology; 2022 Jun; 211():109059. PubMed ID: 35417746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of large myelin protein zero leads to Charcot-Marie-Tooth disease-like neuropathy in mice.
    Otani Y; Ohno N; Cui J; Yamaguchi Y; Baba H
    Commun Biol; 2020 Mar; 3(1):121. PubMed ID: 32170207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P(0) glycoprotein overexpression causes congenital hypomyelination of peripheral nerves.
    Wrabetz L; Feltri ML; Quattrini A; Imperiale D; Previtali S; D'Antonio M; Martini R; Yin X; Trapp BD; Zhou L; Chiu SY; Messing A
    J Cell Biol; 2000 Mar; 148(5):1021-34. PubMed ID: 10704451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major isoform of zebrafish P0 is a 23.5 kDa myelin glycoprotein expressed in selected white matter tracts of the central nervous system.
    Bai Q; Sun M; Stolz DB; Burton EA
    J Comp Neurol; 2011 Jun; 519(8):1580-96. PubMed ID: 21452240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nonsense mutation in myelin protein zero causes congenital hypomyelination neuropathy through altered P0 membrane targeting and gain of abnormal function.
    Fratta P; Ornaghi F; Dati G; Zambroni D; Saveri P; Belin S; D'Adamo P; Shy M; Quattrini A; Laura Feltri M; Wrabetz L
    Hum Mol Genet; 2019 Jan; 28(1):124-132. PubMed ID: 30239779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin preparations attenuate lysolecithin-induced peripheral demyelination in mice and comprise anti-large myelin protein zero antibody.
    Setoguchi Y; Hayashi A; Kawada A; Ibusuki A; Yanaoka D; Saito R; Ishibashi T; Takimoto H; Yamaguchi Y; Ohtaki H; Baba H
    Proc Jpn Acad Ser B Phys Biol Sci; 2023; 99(2):48-60. PubMed ID: 36775342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal expression of myelin protein zero with frame-shift mutation correlates with mild phenotype.
    Steck AJ; Erne B; Pareyson D; Sghirlanzoni A; Taroni F; Schaeren-Wiemers N
    J Peripher Nerv Syst; 2006 Mar; 11(1):61-6. PubMed ID: 16519783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic clustering in MPZ mutations.
    Shy ME; Jáni A; Krajewski K; Grandis M; Lewis RA; Li J; Shy RR; Balsamo J; Lilien J; Garbern JY; Kamholz J
    Brain; 2004 Feb; 127(Pt 2):371-84. PubMed ID: 14711881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ
    Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel myelin protein zero transgenic zebrafish designed for rapid readout of in vivo myelination.
    Preston MA; Finseth LT; Bourne JN; Macklin WB
    Glia; 2019 Apr; 67(4):650-667. PubMed ID: 30623975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe demyelinating hypertrophic polyneuropathy caused by a de novo frameshift mutation within the intracellular domain of myelin protein zero (MPZ/P0).
    Zschüntzsch J; Dibaj P; Pilgram S; Kötting J; Gerding WM; Neusch C
    J Neurol Sci; 2009 Jun; 281(1-2):113-5. PubMed ID: 19344920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P0 (protein zero) mutation S34C underlies instability of internodal myelin in S63C mice.
    Avila RL; D'Antonio M; Bachi A; Inouye H; Feltri ML; Wrabetz L; Kirschner DA
    J Biol Chem; 2010 Dec; 285(53):42001-12. PubMed ID: 20937820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How Does Protein Zero Assemble Compact Myelin?
    Raasakka A; Kursula P
    Cells; 2020 Aug; 9(8):. PubMed ID: 32759708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major myelin protein gene (P0) mutation causes a novel form of axonal degeneration.
    Li J; Bai Y; Ianakova E; Grandis M; Uchwat F; Trostinskaia A; Krajewski KM; Garbern J; Kupsky WJ; Shy ME
    J Comp Neurol; 2006 Sep; 498(2):252-65. PubMed ID: 16856127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactivity of PMP-22, P0, and other 19 to 28 kDa glycoproteins in peripheral nerve myelin of mammals and fish with HNK1 and related antibodies.
    Hammer JA; O'Shannessy DJ; De Leon M; Gould R; Zand D; Daune G; Quarles RH
    J Neurosci Res; 1993 Aug; 35(5):546-58. PubMed ID: 7690857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelin protein zero and membrane adhesion.
    Spiryda LB
    J Neurosci Res; 1998 Oct; 54(2):137-46. PubMed ID: 9788273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the cytoplasmic domain of P0 reveal a role for PKC-mediated phosphorylation in adhesion and myelination.
    Xu W; Shy M; Kamholz J; Elferink L; Xu G; Lilien J; Balsamo J
    J Cell Biol; 2001 Oct; 155(3):439-46. PubMed ID: 11673479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rare myelin protein zero (MPZ) variant alters enhancer activity in vitro and in vivo.
    Antonellis A; Dennis MY; Burzynski G; Huynh J; Maduro V; Hodonsky CJ; Khajavi M; Szigeti K; Mukkamala S; Bessling SL; Pavan WJ; McCallion AS; Lupski JR; Green ED;
    PLoS One; 2010 Dec; 5(12):e14346. PubMed ID: 21179557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.